『What Pharma Needs Next』のカバーアート

What Pharma Needs Next

What Pharma Needs Next

著者： Veeva Systems
無料で聴く

このコンテンツについて

 What Pharma Needs Next is a podcast for commercial and medical leaders. You’ll hear from life sciences experts on the trends re-shaping biopharma, how technology and data are accelerating their vital work, and ways to improve customer-centricity in the face of HCP and KOL access challenges.© Copyright 2024 Veeva Systems 生物科学 科学 経済学
エピソード
  • UCB and Takeda: Improving the Customer Experience through Medical-Commercial Collaboration

    UCB and Takeda: Improving the Customer Experience through Medical-Commercial Collaboration
    2025/10/06

    What happens when medical and commercial teams truly align? Stronger launches, a smoother HCP experience, and better patient outcomes. In this episode, Christoph Bug speaks with Pascal Vande Gucht of UCB and Georgios Tramountanis of Takeda about breaking down silos and creating unified, cross-functional strategies. They explore how visibility, shared messaging, and thoughtful change management fuel collaboration–and how tools like GenAI and data platforms are driving the next wave of transformation.

    続きを読む 一部表示
    22 分
  • Turning Content into Memorable Customer Experiences

    Turning Content into Memorable Customer Experiences
    2025/06/04

    How does great content become memorable customer experiences in life sciences? Erica Taylor and Oz Demir of Genentech share their recent experiences of spearheading marketing transformation, including success factors as you get started and how to think about behavioral change. They explain the novel ways their teams are using data and automation to deliver on business goals to quickly scale personalized content for customers.
    続きを読む 一部表示
    22 分
  • Preparing for a Faster Trial-to-Treatment Pathway

    Preparing for a Faster Trial-to-Treatment Pathway
    2024/11/29

    Pharmaphorum’s Nicole Raleigh interviews Chris Moore, president of Veeva Europe, on trends shaping commercial life sciences. Chris highlights AI’s potential use cases, the need for caution, and how commercial and medical leaders are overcoming access challenges to accelerate treatment pathways.
    続きを読む 一部表示
    27 分
まだレビューはありません